Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Outstanding (2019 - 2025)

Historic Shares Outstanding for BridgeBio Pharma (BBIO) over the last 7 years, with Q2 2025 value amounting to $191.2 million.

  • BridgeBio Pharma's Shares Outstanding rose 166.46% to $191.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $191.2 million, marking a year-over-year increase of 166.46%. This contributed to the annual value of $190.0 million for FY2024, which is 854.54% up from last year.
  • Per BridgeBio Pharma's latest filing, its Shares Outstanding stood at $191.2 million for Q2 2025, which was up 166.46% from $189.8 million recorded in Q1 2025.
  • In the past 5 years, BridgeBio Pharma's Shares Outstanding ranged from a high of $191.2 million in Q2 2025 and a low of $147.1 million during Q3 2021
  • Over the past 5 years, BridgeBio Pharma's median Shares Outstanding value was $160.9 million (recorded in 2023), while the average stood at $166.4 million.
  • Per our database at Business Quant, BridgeBio Pharma's Shares Outstanding surged by 2286.98% in 2021 and then crashed by 95.65% in 2022.
  • BridgeBio Pharma's Shares Outstanding (Quarter) stood at $147.3 million in 2021, then increased by 2.23% to $150.6 million in 2022, then rose by 16.24% to $175.1 million in 2023, then increased by 8.55% to $190.0 million in 2024, then grew by 0.59% to $191.2 million in 2025.
  • Its last three reported values are $191.2 million in Q2 2025, $189.8 million for Q1 2025, and $190.0 million during Q4 2024.